Suppr超能文献

固相肿瘤荧光引导手术中 uPAR 靶向光学成像抗体和抗体片段的并排比较。

Side-by-Side Comparison of uPAR-Targeting Optical Imaging Antibodies and Antibody Fragments for Fluorescence-Guided Surgery of Solid Tumors.

机构信息

Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.

Unit of Immunology and General Pathology, Department of Molecular Medicine, University of Pavia, Pavia, Italy.

出版信息

Mol Imaging Biol. 2023 Feb;25(1):122-132. doi: 10.1007/s11307-021-01657-2. Epub 2021 Oct 12.

Abstract

PURPOSE

Radical resection is paramount for curative oncological surgery. Fluorescence-guided surgery (FGS) aids in intraoperative identification of tumor-positive resection margins. This study aims to assess the feasibility of urokinase plasminogen activator receptor (uPAR) targeting antibody fragments for FGS in a direct comparison with their parent IgG in various relevant in vivo models.

PROCEDURES

Humanized anti-uPAR monoclonal antibody MNPR-101 (uIgG) was proteolytically digested into F(ab')2 and Fab fragments named uFab2 and uFab. Surface plasmon resonance (SPR) and cell assays were used to determine in vitro binding before and after fluorescent labeling with IRDye800CW. Mice bearing subcutaneous HT-29 human colonic cancer cells were imaged serially for up to 120 h after fluorescent tracer administration. Imaging characteristics and ex vivo organ biodistribution were further compared in orthotopic pancreatic ductal adenocarcinoma (BxPc-3-luc2), head-and-neck squamous cell carcinoma (OSC-19-luc2-GFP), and peritoneal carcinomatosis (HT29-luc2) models using the clinical Artemis fluorescence imaging system.

RESULTS

Unconjugated and conjugated uIgG, uFab2, and uFab specifically recognized uPAR in the nanomolar range as determined by SPR and cell assays. Subcutaneous tumors were clearly identifiable with tumor-to-background ratios (TBRs) > 2 after 72 h for uIgG-800F and 24 h for uFab2-800F and uFab-800F. For the latter two, mean fluorescence intensities (MFIs) dipped below predetermined threshold after 72 h and 36 h, respectively. Tumors were easily identified in the orthotopic models with uIgG-800F consistently having the highest MFIs and uFab2-800F and uFab-800F having similar values. In biodistribution studies, kidney and liver fluorescence approached tumor fluorescence after uIgG-800F administration and surpassed tumor fluorescence after uFab2-800F or uFab-800F administration, resulting in interference in the abdominal orthotopic mouse models.

CONCLUSIONS

In a side-by-side comparison, FGS with uPAR-targeting antibody fragments compared with the parent IgG resulted in earlier tumor visualization at the expense of peak fluorescence intensity.

摘要

目的

根治性切除术是癌症手术治疗的关键。荧光引导手术(FGS)有助于术中识别肿瘤阳性切缘。本研究旨在评估尿激酶型纤溶酶原激活物受体(uPAR)靶向抗体片段在各种相关体内模型中与亲本 IgG 进行直接比较时用于 FGS 的可行性。

程序

人源化抗-uPAR 单克隆抗体 MNPR-101(uIgG)经蛋白水解酶切割成 F(ab')2 和 Fab 片段,分别命名为 uFab2 和 uFab。使用表面等离子体共振(SPR)和细胞测定法在荧光标记前后确定体外结合,荧光标记物为 IRDye800CW。在荧光示踪剂给药后长达 120 小时内,对皮下携带 HT-29 人结肠癌细胞的小鼠进行连续成像。使用临床 Artemis 荧光成像系统,在原位胰腺导管腺癌(BxPc-3-luc2)、头颈部鳞状细胞癌(OSC-19-luc2-GFP)和腹膜癌(HT29-luc2)模型中进一步比较成像特征和器官外分布。

结果

未缀合和缀合的 uIgG、uFab2 和 uFab 均通过 SPR 和细胞测定法以纳摩尔级特异性识别 uPAR。皮下肿瘤在 72 小时后,uIgG-800F 和 24 小时后 uFab2-800F 和 uFab-800F 的肿瘤与背景比(TBR)>2 时可清晰识别。对于后两者,平均荧光强度(MFI)分别在 72 小时和 36 小时后低于预定阈值。在用 uIgG-800F 进行治疗后,在原位模型中很容易识别肿瘤,uIgG-800F 始终具有最高的 MFI,uFab2-800F 和 uFab-800F 具有相似的 MFI。在分布研究中,在用 uIgG-800F 给药后,肾脏和肝脏的荧光接近肿瘤荧光,在用 uFab2-800F 或 uFab-800F 给药后超过肿瘤荧光,导致腹部原位小鼠模型出现干扰。

结论

在并排比较中,与亲本 IgG 相比,使用 uPAR 靶向抗体片段进行 FGS 导致更早的肿瘤可视化,但牺牲了峰值荧光强度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/412f/9970952/84127fa171ad/11307_2021_1657_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验